enVVeno Medical Corporation (NASDAQ:NVNO) · earnings preview
Quarter
Q3
EPS estimate to actual
-$3.27
At a glance
Key takeaways
01enVVeno Medical (NVNO) reports Q3 earnings on October 30, 2026, with analysts expecting a loss of $3.27 per share versus breakeven in the prior year.
02The company has a market capitalization of $7.3M and stock price of $6.87, indicating a small-cap healthcare business.
03Recent quarters show significant losses, with Q4 2026 at $6.05 per share loss and Q1 2026 at $5.89 per share loss.
04Revenue expectations for Q3 were not disclosed in the article, limiting visibility into top-line performance trends.
Earnings Results
enVVeno Medical Corporation (NASDAQ:NVNO) is scheduled to report its Q3 earnings results on October 30, 2026 after market close.
Analysts expect the Healthcare company to report earnings per share of $-3.27, below the $0.00 reported in the same quarter last year. Revenue is expected to come in at , down from a year ago.
Company Overview
The stock currently trades at $6.87 with a market capitalization of $7.3M.
Ahead of enVVeno Medical Corporation's earnings report, investors are watching several key metrics beyond the headline EPS number. Revenue growth, margin trends, and forward guidance will likely carry more weight than a single quarter's earnings figure in determining the stock's direction after the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking enVVeno Medical Corporation should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.